Strategies for commercial success of biosimilars in an increasingly crowded market place
Add to your list(s)
Download to your calendar using vCal
If you have a question about this talk, please contact Dr Shara Cohen.
http://www.regonline.co.uk/biosimilars2012
Whilst biopharmaceuticals remain a major component of the global therapeutics market, the ever expanding portfolio of products losing patent protection and with increasing healthcare costs remaining a poignant issue, the opportunity for development of competing, follow on biologics remains an attractive proposition for both Biotech and Pharma companies alike. This Euroscicon biosimilars conference will focus on multiple aspects of biosimilar product development to successfully deliver safe, biosimilar products to the market place.
This talk is part of the Euroscicon series.
This talk is included in these lists:
Note that ex-directory lists are not shown.
|